CA9 and breast neoplasm: CAIX is upregulated in hypoxic tumors, where it is a marker for distant metastasis and poor survival, while depletion of CAIX expression or pharmacologic inhibition of its activity significantly constrains breast tumor growth and metastasis formation in vivo [108].